BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36056910)

  • 21. Reflectance Confocal Microscopy in Lentigo Maligna.
    Gamo R; Pampín A; Floristán U
    Actas Dermosifiliogr; 2016 Dec; 107(10):830-835. PubMed ID: 27614735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentigo Maligna.
    Franke JD; Woolford KM; Neumeister MW
    Clin Plast Surg; 2021 Oct; 48(4):669-675. PubMed ID: 34503727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Key dermoscopic signs in the diagnosis and progression of extrafacial lentigo maligna: Evaluation of a series of 41 cases.
    Gamo-Villegas R; Pampín-Franco A; Floristán-Murúzabal U; García-Zamora E; Pinedo-Moraleda F; López-Estebaranz JL
    Australas J Dermatol; 2019 Nov; 60(4):288-293. PubMed ID: 30997681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of dermoscopic features among lentigo senilis/initial seborrheic keratosis, seborrheic keratosis, lentigo maligna and lentigo maligna melanoma on the face.
    Sahin MT; Oztürkcan S; Ermertcan AT; Güneş AT
    J Dermatol; 2004 Nov; 31(11):884-9. PubMed ID: 15729860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo confocal scanning laser microscopy of benign lentigines: comparison to conventional histology and in vivo characteristics of lentigo maligna.
    Langley RG; Burton E; Walsh N; Propperova I; Murray SJ
    J Am Acad Dermatol; 2006 Jul; 55(1):88-97. PubMed ID: 16781299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
    Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
    Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentigo maligna and lentigo maligna melanoma.
    Johr RH; Stolz W
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):512. PubMed ID: 9308580
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case-control study.
    Gouveia BM; Carlos G; Wadell A; Sinz C; Ahmed T; Lo SN; Rawson RV; Ferguson PM; Scolyer RA; Guitera P
    J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1293-1301. PubMed ID: 36855833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lentigo maligna: review of salient characteristics and management.
    Kallini JR; Jain SK; Khachemoune A
    Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentigo maligna melanoma--the review.
    Situm M; Bolanca Z; Buljan M
    Coll Antropol; 2010 Apr; 34 Suppl 2():299-301. PubMed ID: 21305747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentigo maligna and lentigo maligna melanoma.
    Cohen LM
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):913. PubMed ID: 9204053
    [No Abstract]   [Full Text] [Related]  

  • 32. Dermoscopic predictors to discriminate between in situ and early invasive lentigo maligna melanoma: A retrospective observational study.
    Peruilh-Bagolini L; Apalla Z; González-Cuevas R; Lallas K; Papageorgiou C; Bobos M; Manoli SM; Gkentsidi T; Spyridis I; Lazaridou E; Sotiriou E; Vakirlis E; Ioannides D; Lallas A
    J Am Acad Dermatol; 2020 Jul; 83(1):269-271. PubMed ID: 32199898
    [No Abstract]   [Full Text] [Related]  

  • 33. Melanoma on chronically sun-damaged skin: Lentigo maligna and desmoplastic melanoma.
    DeWane ME; Kelsey A; Oliviero M; Rabinovitz H; Grant-Kels JM
    J Am Acad Dermatol; 2019 Sep; 81(3):823-833. PubMed ID: 30930085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nine per cent of biopsy-proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery.
    Zoutendijk J; Tio D; Koljenovic S; van den Bos RR
    Br J Dermatol; 2019 Aug; 181(2):383-384. PubMed ID: 30716164
    [No Abstract]   [Full Text] [Related]  

  • 35. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
    Flotte TJ; Mihm MC
    Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lentigo Maligna: Keys to Dermoscopic Diagnosis.
    Bollea-Garlatti LA; Galimberti GN; Galimberti RL
    Actas Dermosifiliogr; 2016; 107(6):489-97. PubMed ID: 26875792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence-advanced videodermatoscopy (FAV) for the differential diagnosis of suspicious facial lesions: A single-centre experience with pattern analysis and histopathological correlation.
    Scarfì F; Trane L; Maio V; Silvestri F; Venturi F; Zuccaro B; Massi D; De Giorgi V
    Photodermatol Photoimmunol Photomed; 2022 May; 38(3):266-276. PubMed ID: 34713502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Handheld reflectance confocal microscopy to aid in the management of complex facial lentigo maligna.
    Hibler BP; Yélamos O; Cordova M; Sierra H; Rajadhyaksha M; Nehal KS; Rossi AM
    Cutis; 2017 May; 99(5):346-352. PubMed ID: 28632796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Line-field confocal optical coherence tomography of xanthogranuloma: Correlation with vertical and horizontal histopathology.
    Lacarrubba F; Verzì AE; Puglisi DF; Broggi G; Caltabiano R; Micali G
    J Cutan Pathol; 2021 Sep; 48(9):1208-1211. PubMed ID: 34028070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reflectance confocal microscopy of facial neoplasms: Follicular involvement as a clue to diagnosis.
    Shahriari N; Grant-Kels JM; Rabinovitz H; Oliviero M; Scope A
    J Cutan Pathol; 2023 Feb; 50(2):178-184. PubMed ID: 36321579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.